Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Progyny, Inc. (PGNY)

Nasdaq Health Care Health Care Services S&P SmallCap 600
$34.84
+0.47 (+1.37%)
Close of Nov 06, 2026 · end-of-day data
Source: Progyny, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$48.58M$105.40M$229.68M$344.86M$500.62M$786.91M$1.09B$1.17B$1.29B
Cost of revenue$41.18M$85.97M$184.18M$274.80M$388.49M$619.59M$849.80M$913.86M$984.18M
Gross profit$7.40M$19.43M$45.51M$70.06M$112.14M$167.32M$238.80M$253.36M$304.48M
Research & development————————$9.50M
Operating income-$11.01M-$3.45M$9.68M$8.35M$32.34M$23.34M$62.18M$67.45M$85.28M
Pre-tax income-$12.46M-$6.89M-$8.56M$8.68M$32.44M$24.44M$70.69M$83.20M$95.43M
Income tax-$3.00K-$1.78M$12.00K-$37.78M-$33.33M-$5.92M$8.65M$28.87M$36.91M
Net income-$12.45M$661.00K-$8.57M$46.46M$65.77M$30.36M$62.04M$54.34M$58.52M
EBITDA-$9.45M-$1.57M$11.81M$10.25M$33.64M$24.94M$64.47M$70.63M$90.22M
EPS (basic)$-2.37$0.04$-0.41$0.54$0.74$0.33$0.65$0.59$0.68
EPS (diluted)$-2.37$0.04$-0.41$0.47$0.66$0.30$0.62$0.57$0.65
Diluted shares5.68M5.54M20.74M99.06M100.36M99.96M100.67M95.45M89.86M
Gross margin15.2%18.4%19.8%20.3%22.4%21.3%21.9%21.7%23.6%
Operating margin-22.7%-3.3%4.2%2.4%6.5%3.0%5.7%5.8%6.6%
Net margin-25.6%0.6%-3.7%13.5%13.1%3.9%5.7%4.7%4.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents—$127.00K$80.38M$70.31M$91.41M$120.08M$97.30M$162.31M$112.24M
Short-term investments———$38.99M$28.00M$69.22M$273.79M$65.64M$197.86M
Receivables—$23.32M$47.06M$75.66M$134.56M$240.07M$241.87M$235.32M$220.29M
Total current assets—$24.54M$132.44M$190.22M$258.54M$433.86M$640.41M$472.72M$551.77M
Goodwill—$11.88M$11.88M$11.88M$11.88M$11.88M$11.88M$15.53M$19.98M
Total assets—$41.32M$150.43M$253.93M$358.06M$542.99M$756.62M$607.10M$742.43M
Total current liabilities—$30.20M$36.16M$77.79M$98.82M$159.54M$185.95M$168.63M$202.39M
Short-term debt—$253.00K———————
Total debt—$253.00K———————
Total liabilities—$30.20M$36.16M$86.98M$106.24M$166.02M$203.19M$185.04M$226.39M
Shareholders' equity-$97.62M-$95.11M$114.27M$166.95M$251.82M$376.97M$553.43M$422.06M$516.04M

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$9.47M$2.27M-$1.53M$36.20M$26.04M$80.39M$188.81M$179.10M$210.19M
Capital expenditures$612.00K$579.00K$2.96M$1.04M$2.13M$3.24M$3.64M$5.41M$18.41M
Free cash flow-$10.09M$1.69M-$4.49M$35.17M$23.91M$77.15M$185.17M$173.70M$191.78M
Investing cash flow-$612.00K$1.90M-$2.76M-$40.03M$8.77M-$43.87M-$200.53M$195.79M-$159.01M
Financing cash flow$11.77M-$8.74M$84.55M-$6.25M-$13.70M-$7.86M-$11.07M-$309.88M-$99.36M
Share buybacks—$1.21M$185.00K——$0$0$300.28M$81.66M
Stock-based compensation$1.56M$3.00M$5.06M$12.82M$33.71M$100.75M$122.61M$128.13M$131.87M
Depreciation & amortization$1.56M$1.88M$2.13M$1.91M$1.30M$1.60M$2.28M$3.17M$4.95M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.